Private equity firm SPE Capital has announced the sale of Amanys Pharma to Laprophan, a pharmaceutical company in Morocco, subject to obtaining the required regulatory approvals.
Share this post
SPE Capital exits Moroccan pharma company
Share this post
Private equity firm SPE Capital has announced the sale of Amanys Pharma to Laprophan, a pharmaceutical company in Morocco, subject to obtaining the required regulatory approvals.